More ‘Visibility’ For Investors Into Standalone J&J Consumer Business Needed For Growth – CEO

“There's been not enough investors' visibility to our consumer health business," recently promoted CEO Duato says at JP Morgan conference, With separate business, "investors are going to see the strength of our consumer health business, the number of iconic brands, the global scale and our penetration, the unique relationship that consumer have with our brands."

• Source: Alamy

Marketing some of the world’s best known OTC drug brands isn’t sufficient visibility for Johnson & Johnson’s consumer health business, says CEO Joaquin Duato.

Investors, Duato explained in a presentation during the J.P. Morgan Healthcare Conference, haven’t had access to enough information about the...

HBW Podcast

Explore how consumer health is evolving. On the go.

David Ridley hosts in-depth conversations with industry leaders.

More from Strategy

More from Business